<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352296</url>
  </required_header>
  <id_info>
    <org_study_id>BMR_2020_12</org_study_id>
    <nct_id>NCT04352296</nct_id>
  </id_info>
  <brief_title>Effect of Individualized Versus Standard Bp Management During MT for Anterior Ischemic Stroke</brief_title>
  <acronym>DETERMINE</acronym>
  <official_title>Effect of Individualized Versus Standard Blood Pressure Management During Mechanical Thrombectomy for Anterior Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hopital Lariboisière</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henri Mondor University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Groupe Hospitalier Pitie-Salpetriere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bicetre Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital de la Timone</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Purpan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Gabriel Montpied</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      DETERMINE is a multicenter, prospective, randomised, open, blinded end-point assessed (PROBE)&#xD;
      trial, to evaluate two approaches of blood pressure (BP) management during mechanical&#xD;
      thrombectomy for acute ischemic stroke due to an anterior large vessel occlusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study have to objective to evaluate the efficacy of an individualized BP control during&#xD;
      mechanical thrombectomy (regardless of the sedation modality), by maintaining a mean arterial&#xD;
      pressure (MAP) within 10% of the first MAP measured in the angiography suit, compared to the&#xD;
      standard BP management, on the 3-month functional outcome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 8, 2021</start_date>
  <completion_date type="Anticipated">November 20, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 8, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patient with a favorable functional outcome at 3 months</measure>
    <time_frame>3 months visit</time_frame>
    <description>Rankin score less than 3</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">432</enrollment>
  <condition>Acute Cerebrovascular Accident</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individualized BP management during mechanical thrombectomy with the administration of diluted norepinephrine (5-10 µg/ml) or nicardipine (1 mg/ml) or urpidil (5 mg/ml) to maintain the MAP within 10% of the first MAP measured in the angiography suit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard BP management based on international guidelines: Treatment of hypotension defined by a systolic blood pressure &lt;140 mm Hg, and treatment of hypertension defined by a systolic blood pressure &gt; 180 mm Hg or diastolic blood pressure &gt;105 mm Hg) with usual treatments (norepinephrine, ephedrine or phenylephrine for hypotension; intravenous nicardipine or uradipil for hypertension).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Individualized blood pressure</intervention_name>
    <description>Individualized blood pressure management during mechanical thrombectomy with the administration of diluted norepinephrine (5-10 µg/ml) or nicardipine (1 mg/ml) or urpidil (5 mg/ml) to maintain the MAP within 10% of the first MAP measured in the angiography suit</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard blood pressure</intervention_name>
    <description>Standard blood pressure management based on international guidelines: Treatment of hypotension defined by a systolic blood pressure &lt;140 mm Hg, and treatment of hypertension defined by a systolic blood pressure &gt; 180 mm Hg or diastolic blood pressure &gt;105 mm Hg) with usual treatments (norepinephrine, ephedrine or phenylephrine for hypotension; intravenous nicardipine or uradipil for hypertension).</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years old&#xD;
&#xD;
          -  Acute ischemic stroke due to an anterior large vessel occlusion: occlusion of the M1&#xD;
             or M2 segments of the middle cerebral artery, anterior cerebral artery (A1 segment),&#xD;
             intracranial internal carotid artery, or tandem occlusions.&#xD;
&#xD;
          -  Indication for mechanical thrombectomy under general anesthesia or conscious sedation&#xD;
             within the first 6 hours from symptoms onset or within the first 24 hours if DAWN or&#xD;
             DEFUSE-3 criteria are met.&#xD;
&#xD;
          -  Affiliation to social security assurance.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ContrAindication to mechanical thrombectomy&#xD;
&#xD;
          -  Intubation or induction of general anaesthesia prior to randomization&#xD;
&#xD;
          -  Acute ischemic strokes associated with a posterior circulation large vessel occlusion&#xD;
             (basilar artery, vertebral artery, posterior cerebral artery)&#xD;
&#xD;
          -  Intra-hospital onset of acute ischemic stroke, or secondary to a medical,&#xD;
             interventional or surgical procedure (interventional cardiology, cardiac or vascular&#xD;
             surgery) or any post-surgery ischemic stroke.&#xD;
&#xD;
          -  Pre-existing neurological disability limiting neurological assessment at 3 months: mRS&#xD;
             &gt;2 at randomization.&#xD;
&#xD;
          -  Contraindication to iodinated contrast agents&#xD;
&#xD;
          -  Known pregnancy or breastfeeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>woman and man</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Maier</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Fondation A de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Malek Ben Maacha</last_name>
    <phone>+33148036870</phone>
    <email>mbenmaacha@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Benjamin Maier</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amélie Yavchitz</last_name>
    </contact>
    <investigator>
      <last_name>Benjamin Maier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 10, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 12, 2021</last_update_submitted>
  <last_update_submitted_qc>April 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute ischemic stroke</keyword>
  <keyword>Large vessel occlusion</keyword>
  <keyword>Mechanical thrombectomy</keyword>
  <keyword>Blood pressure management</keyword>
  <keyword>Brain infarction</keyword>
  <keyword>Endovascular procedure</keyword>
  <keyword>Thrombectomy</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Low blood pressure</keyword>
  <keyword>Hemodynamic</keyword>
  <keyword>Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

